1. Wu Y, Hu Y, Tang X, He L, Ren T, Tao Q, Qin X, Sun N, Wang H, Cao W, Wu T, Zhan S, Wang J, Chen W, Li L (2011) Long-term efficacy and tolerability of a fixed-dose combination of antihypertensive agents: an open-label surveillance study in China. Clin Drug Invest 31:769–777
2. European Pharmacopeia 9th edn. (2016) Council of Europe, Strasbourg
3. Raul SK, Ravi Kumar BV, Pattnaik AK, Rao NN (2013) A RP-HPLC method development and validation for the estimation of dihydralazine in bulk and pharmaceutical dosage forms. Int J Pharm 3:116–121
4. Che BQ (2004) Determination of five components in compound hypotensive tablet by HPLC. Acta Pharm Sin 39:618–620
5. Jin PF, Kuang YT, Zou D, Hu X, Jiang WQ, Wu XJ (2011) Simultaneous determination of three active ingredients in compound hypotensive tablets by HPLC. Chin Pharm J 46:152–155